BioCentury
ARTICLE | Clinical News

NicOx Phase I/II HCT 1026 data

July 3, 2000 7:00 AM UTC

NicOx (NM:Nicox) reported data from a study of 16 healthy volunteers with methyl nicotinate-induced skin lesions showing that HCT 1026 ointment gave significant anti-inflammatory activity compared to ...